Intelligence · Clinical Development
Pipeline search results
Programs matching “esketamine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 21 pipeline programs matching "esketamine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Esketamine
Janssen Cilag International NV
Depressive Disorder, Major
1 trial -
Determine the ED50 and ED95 of esketamine
The First People's Hospital of Lianyungang
Intrauterine Polyp
1 trial -
Intravenous esketamine using Dixon's up-and-down sequential method
The First People's Hospital of Lianyungang
Hepatic Neoplasm
1 trial -
Esketamine injection group (0.25 mg/kg)
The First People's Hospital of Lianyungang
Esketamine
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Obstructive Sleep Apnea
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Scoliosis Correction
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postpartum Depression
1 trial -
Esketamine 0.2 mg/kg
The First People's Hospital of Lianyungang
Cesarean Delivery
1 trial -
Esketamine 1
The First People's Hospital of Lianyungang
Elderly
1 trial -
Esketamine combined with dexmedetomidine
The First People's Hospital of Lianyungang
Dexmedetomidine
2 trials -
Intranasal dexmedetomidine-esketamine
The First People's Hospital of Lianyungang
Adenotonsillectomy
1 trial -
Dexmedetomidine-Esketamine Combination
The First People's Hospital of Lianyungang
Aged
1 trial -
Dexmedetomidine-esketamine combination
The First People's Hospital of Lianyungang
Liver Cancer
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Post Induction Hypotension
1 trial -
Esketamine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anesthesia
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial -
Esketamine at low dose
The First People's Hospital of Lianyungang
Insomnia
1 trial -
Esketamine nasal spray
United Therapeutics Europe Ltd
Depression
1 trial -
Esketamine, Sulfentanil or/and Remifentanil
Second Affiliated Hospital of Soochow University
Opioid Analgesic Adverse Reaction
1 trial -
Esketamine-lidocaine group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Postoperative Chronic Pain
1 trial -
esketamine group
The First People's Hospital of Lianyungang
Postherpetic Neuralgia
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.